Gaskins Tammi L sold 5,919 shares of IRONWOOD PHARMACEUTICALS INC at $4.81 for −$28.5k on Nov 16, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Commercial Officer
Chief Commercial Officer
Filed Nov 18, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$28,470.39Shares × reported price
Shares traded
5,919Class A Common Stock
Price per share
$4.81Reported price. Read footnotes for ranges.
% of reported position traded
1.69%This security and ownership context
Holdings after
344,431Direct
Trade date
Nov 16, 2026Sell
Filed
Nov 18, 2026, 4:05 PM ET2-day reporting delay
Accession
0001193125-26-467075Code S · Transaction 405618
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 350,350 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

IRWD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IRWD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 25, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The sale reported on this Form 4 represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the reporting person.